Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit

Objectives: During treatment with selective decontamination of the digestive tract (SDD), four multidrug-resistant (MDR) strains, three different Escherichia coli and one Klebsiella pneumoniae, were isolated from four patients not known as carriers of such MDR strains before their admission to the i...

Full description

Saved in:
Bibliographic Details
Published inJournal of antimicrobial chemotherapy Vol. 58; no. 4; pp. 853 - 856
Main Authors Al Naiemi, Nashwan, Heddema, Edou R., Bart, Aldert, de Jonge, Evert, Vandenbroucke-Grauls, Christina M., Savelkoul, Paul H. M., Duim, Birgitta
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.10.2006
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives: During treatment with selective decontamination of the digestive tract (SDD), four multidrug-resistant (MDR) strains, three different Escherichia coli and one Klebsiella pneumoniae, were isolated from four patients not known as carriers of such MDR strains before their admission to the intensive care unit (ICU) in the Academic Medical Center (AMC) in Amsterdam. These isolates were extended-spectrum β-lactamase (ESBL)-positive. We investigated whether this was due to interspecies transfer of resistance genes. Methods: The MDR strains were typed by amplified fragment length polymorphism (AFLP) analysis. The plasmids from these strains were characterized by restriction fragment length polymorphism and the resistance genes were characterized by PCR and sequence analysis. Results: The strains were genetically unrelated and contained identical plasmids with ESBL genes. Conclusions: We identified an outbreak of plasmid-mediated ESBL genes during SDD treatment in the ICU. The use of third-generation cephalosporins in SDD is associated with the emergence of ESBLs. We conclude that identification of emerging MDR Gram-negative bacteria and recognition of resistance plasmid transfer during SDD treatment are crucial for optimal application of this regimen in ICUs.
Bibliography:ark:/67375/HXZ-W593LPRB-P
istex:2D2B31AC7C575D0995AE3EDABC7679A2DA09AE4D
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/dkl316